GlaxoSmithKline: The AZUR-1 trial reached the primary end, achieving meaningful continuous clinical complete remission at 12 months.

Zhitongcaijing · 2d ago
GlaxoSmithKline: The AZUR-1 trial reached the primary end, achieving meaningful continuous clinical complete remission at 12 months.